Equity Profile

PBH

Prestige Consumer Healthcare Inc.

Health CarePharmaceuticals$2.4B

Aug6Thu

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on pharmaceuticals and consumer health products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and performance this quarter.

Not available

Revenue Growth

Revenue growth will indicate how well the company is expanding its market presence and meeting consumer demand.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PBH Q1-2027 Earnings Preview

Context

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on pharmaceuticals and consumer health products. With a market cap of $2 billion, the company plays a significant role in providing over-the-counter healthcare solutions, which are increasingly important as consumers prioritize health and wellness.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+0.03%

Avg Stock Reaction

+2.05%

Last Quarter Recap

In the last quarter, Prestige Consumer Healthcare reported an EPS of $1.23, which was below the expected $1.39, resulting in an 11.7% surprise. The stock reacted positively, gaining 2.78% the following day despite the miss.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Prestige Consumer Healthcare are mixed, with analysts uncertain about the company's ability to meet or exceed prior performance metrics. Investors are closely watching for any signs of recovery in revenue and profitability.

Bull Case

If the company can demonstrate strong revenue growth and improved EPS, it could signal a turnaround, leading to increased investor confidence and stock appreciation.

Bear Case

Conversely, if the company fails to meet expectations again, it could raise concerns about its competitive position and long-term growth potential, resulting in a negative stock reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter, and how does it compare to last quarter's performance?

This will help determine if the company is on a recovery path or if issues persist, impacting investor sentiment.

How is Prestige Consumer Healthcare addressing market share challenges in key segments?

Understanding the company's strategy to maintain or grow market share is crucial for assessing its competitive position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for Prestige to rebound, as recent consumer trends show a growing demand for over-the-counter health products.

Supporting Evidence

The options market is pricing in a 12.18% move, indicating expectations of volatility that may not align with the company's actual performance.

The recent EPS surprises suggest that the company has the potential to exceed conservative estimates if market conditions improve.

Key Risk

If the company reports an EPS above $1.30, it could challenge the current bearish sentiment and shift investor expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis revolves around whether the company can regain momentum after recent earnings misses and improve its market position.

Bull Confirmed If

A reported EPS of $1.30 or higher would confirm the bull case and indicate a strong recovery.

Bear Confirmed If

An EPS below $1.00 would confirm the bear case and raise concerns about the company's future performance.

Pre-Earnings Positioning

Options Market

Implied Move

±12.18%

Historical Avg

±5.5%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±12.2% while PBH has averaged ±5.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

45.3%

Calls (0)P/C Ratio: 1.50Puts (10K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Prestige reports a strong EPS beat, history suggests the stock could rise by around 5.17%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations but lack strong guidance, the stock may see a muted reaction as investors weigh the cautious outlook.

Miss

A miss on EPS could lead to a decline of about 3.16%, as seen in previous quarters, raising concerns about the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on cost management strategies and their effects on profitability.
3Insights into consumer demand trends for over-the-counter products.
4Details on competitive pressures and how the company plans to address them.
5Any guidance on future earnings expectations and market outlook.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Prestige Consumer Healthcare Inc. (PBH) operates in the health care sector, focusing on pharmaceuticals and consumer health products....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and performance this quarter.

Not available

Revenue Growth

Revenue growth will indicate how well the company is expanding its market presence and meeting consumer demand.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PBH Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+0.03%

Avg Stock Reaction

+2.05%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If the company can demonstrate strong revenue growth and improved EPS, it could signal a turnaround, leading to increased investor confidence and stock appreciation.

Bear Case

Conversely, if the company fails to meet expectations again, it could raise concerns about its competitive position and long-term growth potential, resulting in a negative stock reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter, and how does it compare to last quarter's performance?

This will help determine if the company is on a recovery path or if issues persist, impacting investor sentiment.

How is Prestige Consumer Healthcare addressing market share challenges in key segments?

Understanding the company's strategy to maintain or grow market share is crucial for assessing its competitive position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for Prestige to rebound, as recent consumer trends show a growing demand for over-the-counter health products.

Supporting Evidence

The options market is pricing in a 12.18% move, indicating expectations of volatility that may not align with the company's actual performance.

The recent EPS surprises suggest that the company has the potential to exceed conservative estimates if market conditions improve.

Key Risk

If the company reports an EPS above $1.30, it could challenge the current bearish sentiment and shift investor expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis revolves around whether the company can regain momentum after recent earnings misses and improve its market position.

Bull Confirmed If

A reported EPS of $1.30 or higher would confirm the bull case and indicate a strong recovery.

Bear Confirmed If

An EPS below $1.00 would confirm the bear case and raise concerns about the company's future performance.

Pre-Earnings Positioning

Options Market

Implied Move

±12.18%

Historical Avg

±5.5%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±12.2% while PBH has averaged ±5.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

45.3%

Calls (0)P/C Ratio: 1.50Puts (10K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Prestige reports a strong EPS beat, history suggests the stock could rise by around 5.17%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations but lack strong guidance, the stock may see a muted reaction as investors weigh the cautious outlook.

Miss

A miss on EPS could lead to a decline of about 3.16%, as seen in previous quarters, raising concerns about the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on cost management strategies and their effects on profitability.
3Insights into consumer demand trends for over-the-counter products.
4Details on competitive pressures and how the company plans to address them.
5Any guidance on future earnings expectations and market outlook.